Ipsen has generated impressive organizational momentum, much of it resulting from our carefully chosen partnerships and strategic alliances. As we look to the future, we are actively seeking to expand our internal portfolio of products and development projects through in-licensing, acquisition and co-development partnering transactions. Our primary goal in these partnerships is to provide our development commercialization expertise to companies whose products offer therapeutic benefits to patients with endocrine, metabolic or related orphan diseases.

If you would like to learn more about how you or your company might partner with Ipsen, we invite you to email our Corporate Development team, call (650) 624-4902, or write to:

Tercica, Inc.
Corporate Headquarters
2000 Sierra Point Parkway, Suite 400
Brisbane, CA 94005